0.8 ML adalimumab-fkjp 50 MG/ML Auto-Injector

RxCUI: 2640404
RxNorm name: 0.8 ML adalimumab-fkjp 50 MG/ML Auto-Injector
Display name: 0.8 ML adalimumab-fkjp 50 MG/ML Auto-Injector
Full name: 0.8 ML adalimumab-fkjp 50 MG/ML Auto-Injector
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761154	Hulio	adalimumab-fkjp	351(k) Interchangeable	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Adalimumab	ADALIMUMAB-FKJP	Biocon Biologics Inc	5cde907d-6747-0e62-db25-1718ee717fe7	2026-01-12	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2640404
HULIO	ADALIMUMAB-FKJP	Biocon Biologics Inc	661ad70b-c313-2899-8a7e-7a67bd897ca9	2025-02-06	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2640404

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
661ad70b-c313-2899-8a7e-7a67bd897ca9	adalimumab-fkjp 40 MG in 0.8 ML Auto-Injector [PSN] · 0.8 ML adalimumab-fkjp 50 MG/ML Auto-Injector [SCD] · adalimumab-fkjp 40 MG per 0.8 ML Auto-Injector [SY]	3	11	These highlights do not include all the information needed to use HULIO safely and effectively. See full prescribing information for HULIO . HULIO ® (adalimumab-fkjp) injection, for subcutaneous use Initial U.S. Approval: 2020 HULIO ® (adalimumab-fkjp) is biosimilar* to HUMIRA (adalimumab)	20250206
5cde907d-6747-0e62-db25-1718ee717fe7	adalimumab-fkjp 40 MG in 0.8 ML Auto-Injector [PSN] · 0.8 ML adalimumab-fkjp 50 MG/ML Auto-Injector [SCD] · adalimumab-fkjp 40 MG per 0.8 ML Auto-Injector [SY]	3	4	These highlights do not include all the information needed to use Adalimumab-fkjp safely and effectively. See full prescribing information for Adalimumab-fkjp . Adalimumab-fkjp injection, for subcutaneous use Initial U.S. Approval: 2020 This product is HULIO (Adalimumab-fkjp). HULIO is biosimilar* to HUMIRA (adalimumab)	20250206